- Home
- SBRA vs ASH Comparison
SBRA vs ASH Comparison
Compare SBRA & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBRA
- ASH
- Stock Information
- Founded
- SBRA 2010
- ASH 1924
- Country
- SBRA United States
- ASH United States
- Employees
- SBRA N/A
- ASH N/A
- Industry
- SBRA Real Estate Investment Trusts
- ASH Specialty Chemicals
- Sector
- SBRA Real Estate
- ASH Consumer Discretionary
- Exchange
- SBRA Nasdaq
- ASH Nasdaq
- Market Cap
- SBRA 4.3B
- ASH 4.1B
- IPO Year
- SBRA N/A
- ASH N/A
- Fundamental
- Price
- SBRA $16.95
- ASH $71.98
- Analyst Decision
- SBRA Buy
- ASH Buy
- Analyst Count
- SBRA 6
- ASH 7
- Target Price
- SBRA $19.50
- ASH $101.00
- AVG Volume (30 Days)
- SBRA 2.3M
- ASH 497.8K
- Earning Date
- SBRA 10-31-2024
- ASH 01-28-2025
- Dividend Yield
- SBRA 7.08%
- ASH 2.25%
- EPS Growth
- SBRA N/A
- ASH 1.05
- EPS
- SBRA 0.41
- ASH 3.35
- Revenue
- SBRA $682,324,000.00
- ASH $2,113,000,000.00
- Revenue This Year
- SBRA N/A
- ASH N/A
- Revenue Next Year
- SBRA $6.59
- ASH $3.97
- P/E Ratio
- SBRA $41.56
- ASH $18.19
- Revenue Growth
- SBRA 20.53
- ASH N/A
- 52 Week Low
- SBRA $12.83
- ASH $71.56
- 52 Week High
- SBRA $20.03
- ASH $102.50
- Technical
- Relative Strength Index (RSI)
- SBRA 29.64
- ASH 31.92
- Support Level
- SBRA $17.27
- ASH $72.83
- Resistance Level
- SBRA $17.93
- ASH $74.57
- Average True Range (ATR)
- SBRA 0.41
- ASH 1.64
- MACD
- SBRA -0.14
- ASH -0.21
- Stochastic Oscillator
- SBRA 6.37
- ASH 9.96
About SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.